Sarah C.P. Williams on Muck Rack

Sarah C.P. Williams

(She/Her)
Alexandria
As seen in: Medium, BBC, Wiley, Stanford University, The Conversation, UCLA Newsroom, Phys.org, Liverpool Echo, National Review, The Culture Trip and
Covers:  I write very broadly about anything that can be called science, but my usual focus is biology and medicine.
Freelance science writer.

Get in touch with Sarah C.P.

Contact Sarah C.P., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Sarah C.P. Williams’s Biography

Read Full Bio →

An award-winning freelance science writer with more than 15 years of experience working in journalistic, institutional, and PR settings.

Articles

Customizable AI tool helps pathologists identify diseased cells

|
By Sarah C.P. Williams
| Medical Xpress Verified
It's something nearly any pathologist would welcome: a personally trained assistant that can help them identify abnormal cells in blood samples and biopsies so they can more quickly and accurately diagnose cancer or other diseases. In recent years, that kind of image analysis assistance has become more accessible than ever, thanks to artificial intelligence.
Open in Who Shared Issue with article?

UCLA researchers detail how prostate cancers grow more aggressively to evade treatment

|
By Sarah C.P. Williams
| UCLA Newsroom Verified
Key takeaways Some prostate cancers evolve into a rare, treatment-resitant tumor known as a small cell neuroendocrine, or SCN, cancer. Using mice, UCLA researchers recorded and detailed the molecular steps that transform a more common type of prostate cancer into an SCN cancer. They found prostate adenocarcinomas followed two predictable paths to evolve into SCN cancers, which could lead to new therapies to prevent progression.
Open in Who Shared View Duplicates (2) Issue with article?

Children with deadly immune disorders remain healthy a decade after being treated with gene therapy

|
By Sarah C.P. Williams
| Genetic Literacy Project
O ver a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder. They now report that the effects of the therapy appear to be long-lasting, with 90% of patients who received the treatment eight to 11 years ago still disease-free.
Open in Who Shared Issue with article?
See all 225 licensed articles (247 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified